GlassScriptPhysician profile
John W Aldridge
NPI 1811966773
$42,842.35
in general payments reported to CMS, 2019-2025
35 companies · $1,527 in 2025
The $1,527 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $5,650 · 2021: $2,950 · 2022: $8,371 · 2023: $3,689 · 2024: $3,121 · 2025: $1,527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,707 · Travel and Lodging: $3,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,706.74 |
| Travel and Lodging | $3,630.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14,379.17 | 2019-2025 | Pico, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Exactech, INC. | $8,638.37 | 2019-2023 | |
| Stryker Corporation | $7,612.13 | 2019-2025 | Mako, Triathlon, Restoration |
| Cerapedics INC. | $4,461.66 | 2022 | |
| Si-Bone, INC. | $1,650.39 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,077.80 | 2022-2025 | Persona, Comprehensive Shoulder System, Tricera Handpiece |
| Fortis Surgical, LLC | $820.82 | 2024-2025 | |
| Shoulder Innovations, INC. | $747.04 | 2023 | Inset System |
| Alevio, LLC | $676.46 | 2019 | |
| Nanovis LLC | $515.08 | 2021-2022 | |
| Depuy Synthes Sales INC. | $320.99 | 2019-2024 | Fms, Vapr, Conduit |
| Amgen INC. | $224.47 | 2021-2025 | Evenity, Prolia, Prolia |
| Arthrex, INC. | $204.95 | 2024 | |
| Ortho Development Corporation | $182.96 | 2020 | |
| Sanara Medtech INC. | $145.03 | 2021-2025 | Celleraterx |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $125.33 | 2021 | |
| Bone Support INC. | $123.64 | 2020 | |
| Heron Therapeutics, INC. | $119.21 | 2024 | Zynrelef |
| Electronic Waveform Lab, INC. | $115.17 | 2021-2023 | |
| Engage Uni, LLC | $114.00 | 2020 | |
| Siemens Medical Solutions USA, INC. | $111.94 | 2021 | |
| Innovation Technologies INC | $104.00 | 2021 | |
| Bioventus LLC | $68.57 | 2021-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Curonix LLC | $53.75 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $51.44 | 2019 | |
| Ferring Pharmaceuticals INC. | $46.03 | 2019-2022 | |
| Painteq LLC | $35.70 | 2024 | Painteq |
| Abbott Laboratories | $23.91 | 2025 | Proclaim |
| Medtronic, INC. | $20.78 | 2023 | Intellis Adaptivestim |
| Avanos Medical | $17.37 | 2023 | Trivisc Sodium Hyaluronate |
| Fidia Pharma USA INC. | $14.74 | 2022 | |
| Pacira Therapeutics, INC. | $13.52 | 2021 | |
| Globus Medical, INC. | $13.12 | 2021 | |
| Endo Pharmaceuticals INC. | $12.81 | 2023 | Xiaflex |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,711,337.16 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Aldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.